Article Text

Download PDFPDF
Topical timolol and serum lipoproteins.
  1. J West and
  2. S Longstaff
  1. Department of Ophthalmology, Royal Hallamshire Hospital, Sheffield.


    Oral timolol taken for the treatment of systemic hypertension has been shown to affect adversely serum lipoprotein levels. In a 15-week study on 19 patients topical timolol therapy for raised intraocular pressure was found to have no significant adverse effect on serum lipoprotein levels. This is reassuring in view of the large number of patients on this form of long term therapy, and selection of the type of beta blocker to use should not be influenced by lipid changes associated with the oral form of the drug.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles

    • Research Article
      D L Diehl A L Coleman H D Jampel H A Quigley P S Bachorik
    • Research Article
      P W Joyce P S Raj